18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
to 9 11 9 11 O
â‰¤ 12 13 12 13 O
65 14 16 14 16 B-upper_bound
years 17 22 17 22 I-upper_bound
of 23 25 23 25 O
age 26 29 26 29 B-age

At 0 2 30 32 O
Screening 3 12 33 42 O
and 13 16 43 46 O
Visit 17 22 47 52 O
1 23 24 53 54 O
( 25 26 55 56 O
Baseline 26 34 56 64 O
/ 34 35 64 65 O
Day 35 38 65 68 O
1 39 40 69 70 O
) 40 41 70 71 O
, 41 42 71 72 O
have 43 47 73 77 O
had 48 51 78 81 O
DLE 52 55 82 85 B-clinical_variable
covering 56 64 86 94 O
at 65 67 95 97 O
least 68 73 98 103 O
5 74 75 104 105 B-lower_bound
% 75 76 105 106 I-lower_bound
of 77 79 107 109 O
total 80 85 110 115 B-clinical_variable
body 86 90 116 120 I-clinical_variable
surface 91 98 121 128 I-clinical_variable
area 99 103 129 133 I-clinical_variable
( 104 105 134 135 I-clinical_variable
BSA 105 108 135 138 I-clinical_variable
) 108 109 138 139 I-clinical_variable
or 110 112 140 142 O
SLE 113 116 143 146 B-clinical_variable
with 117 121 147 151 I-clinical_variable
DLE 122 125 152 155 I-clinical_variable
covering 126 134 156 164 O
at 135 137 165 167 O
least 138 143 168 173 O
2 144 145 174 175 B-lower_bound
% 145 146 175 176 I-lower_bound
of 147 149 177 179 O
BSA 150 153 180 183 O
as 154 156 184 186 O
determined 157 167 187 197 O
by 168 170 198 200 O
the 171 174 201 204 O
hand 175 179 205 209 O
print 180 185 210 215 O
method 186 192 216 222 O
( 193 194 223 224 O
one 194 197 224 227 O
palm 198 202 228 232 O
is 203 205 233 235 O
equivalent 206 216 236 246 O
to 217 219 247 249 O
1 220 221 250 251 O
% 221 222 251 252 O
BSA 223 226 253 256 O
) 226 227 256 257 O

Concomitant 0 11 258 269 O
use 12 15 270 273 O
of 16 18 274 276 O
moderate 19 27 277 285 O
to 28 30 286 288 O
potent 31 37 289 295 O
inhibitors 38 48 296 306 O
and 49 52 307 310 O
inducers 53 61 311 319 O
of 62 64 320 322 O
CYP3A4/5 65 73 323 331 B-treatment

Other 0 5 332 337 O
skin 6 10 338 342 O
conditions 11 21 343 353 O
at 22 24 354 356 O
Baseline 25 33 357 365 O
that 34 38 366 370 O
would 39 44 371 376 O
interfere 45 54 377 386 O
with 55 59 387 391 O
evaluation 60 70 392 402 O
of 71 73 403 405 O
DLE 74 77 406 409 B-chronic_disease

Systemic 0 8 410 418 B-treatment
therapy 9 16 419 426 I-treatment
is 17 19 427 429 O
allowed 20 27 430 437 O
if 28 30 438 440 O
on 31 33 441 443 O
a 34 35 444 445 O
stable 36 42 446 452 O
dose 43 47 453 457 O
and 48 51 458 461 O
using 52 57 462 467 O
for 58 61 468 471 O
at 62 64 472 474 O
least 65 70 475 480 O
3 71 72 481 482 B-lower_bound
months 73 79 483 489 I-lower_bound
-background 80 91 490 501 O
therapies 92 101 502 511 O
outlined 102 110 512 520 O
in 111 113 521 523 O
Protocol 114 122 524 532 O

Topical 0 7 533 540 B-treatment
corticosteroid 8 22 541 555 I-treatment
within 23 29 556 562 O
the 30 33 563 566 O
past 34 38 567 571 B-upper_bound
2 39 40 572 573 I-upper_bound
weeks 41 46 574 579 I-upper_bound

Women 0 5 580 585 B-gender
of 6 8 586 588 O
childbearing 9 21 589 601 O
potential 22 31 602 611 O
must 32 36 612 616 O
use 37 40 617 620 B-contraception_consent
effective 41 50 621 630 I-contraception_consent
contraceptive 51 64 631 644 I-contraception_consent
methods 65 72 645 652 I-contraception_consent
in 73 75 653 655 O
order 76 81 656 661 O
to 82 84 662 664 O
participate 85 96 665 676 O
in 97 99 677 679 O
tofacitinib 100 111 680 691 B-treatment
clinical 112 120 692 700 O
studies 121 128 701 708 O

Women 0 5 709 714 B-gender
who 6 9 715 718 O
are 10 13 719 722 B-pregnancy
pregnant 14 22 723 731 I-pregnancy
or 23 25 732 734 O
wish 26 30 735 739 B-pregnancy
to 31 33 740 742 I-pregnancy
become 34 40 743 749 I-pregnancy
pregnant 41 49 750 758 I-pregnancy
, 49 50 758 759 O
or 51 53 760 762 O
who 54 57 763 766 O
are 58 61 767 770 O
lactating 62 71 771 780 O

with 0 4 781 785 O
clinical 5 13 786 794 O
diagnosis 14 23 795 804 O
of 24 26 805 807 O
DLE 27 30 808 811 B-chronic_disease
( 31 32 812 813 O
and 32 35 813 816 O
at 36 38 817 819 O
least 39 44 820 825 O
half 45 49 826 830 O
of 50 52 831 833 O
patients 53 61 834 842 O
with 62 66 843 847 O
a 67 68 848 849 O
diagnosis 69 78 850 859 O
of 79 81 860 862 O
SLE 82 85 863 866 B-chronic_disease
) 85 86 866 867 O
as 87 89 868 870 O
determined 90 100 871 881 O
by 101 103 882 884 O
the 104 107 885 888 O
Principal 108 117 889 898 O
Investigator 118 130 899 911 O
by 131 133 912 914 O
medical 134 141 915 922 O
history 142 149 923 930 O
and 150 153 931 934 O
physical 154 162 935 943 O
exam 163 167 944 948 O

